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Diet and asthma: vitamins and methyl donors
Yueh-Ying Han*, Josh Blatter*, John M Brehm, Erick Forno, Augusto A Litonjua, Juan C Celedón
Diet changes can partly explain the high burden of asthma in industrialised nations. Findings from experimental 
studies have stimulated many observational studies of the association between vitamins (A, C, D, and E) or nutrients 
acting as methyl donors (folate, vitamin B12, and choline) and asthma. However, observational studies are susceptible 
to several sources of bias; well conducted randomised controlled trials (RCTs) are the gold standard to establish 
whether diet has an eﬀ ect on asthma. Evidence from observational studies and a few RCTs strongly justiﬁ es ongoing 
and future RCTs in three areas: vitamin D for the prevention or treatment of asthma, choline supplementation as 
adjuvant treatment for asthma, and vitamin E to prevent the detrimental eﬀ ects of air pollution in patients with 
asthma. At present, insuﬃ  cient evidence exists to recommend supplementation with any vitamin or nutrient acting 
as a methyl donor to prevent or treat asthma.
Introduction
Asthma is a major public health problem in the USA1 and 
worldwide.2 Whereas the prevalence of asthma in 
industrialised nations has reached a relative plateau (after 
a sharp rise from the 1960s to the 1990s), asthma prevalence 
has continued to increase in many non-industrialised 
countries.1,2 The causes of this global asthma epidemic are 
largely unidentiﬁ ed; they are probably multifactorial and 
might include changes in diet—eg, decreased consumption 
of fruits and vegetables and increased intake of reﬁ ned 
grains, red meats, and saturated fats.3
In this Review we examine evidence of a link between 
two groups of dietary components that have been 
extensively studied in connection with asthma: vitamins 
(A, C, D, and E) and nutrients acting as methyl donors 
(folate, vitamin B12, and choline). In view of the fact that 
atopy (allergic sensitisation) is common in individuals 
with asthma, particularly children, we also review 
ﬁ ndings for atopy or atopic diseases (eg, atopic dermatitis) 
where applicable.
Vitamins with antioxidant properties and asthma
Vitamin A
Oxidative stress, resulting from an imbalance between 
reactive oxidant species and antioxidants, can lead to 
tissue damage, airway inﬂ ammation, abnormal immune 
responses,4,5 and increased asthma severity.6 Antioxidant 
defences include endogenous antioxidant enzymes and 
exogenous agents from the diet. Serum concentrations of 
antioxidants have been positively associated with forced 
expiratory volume in 1 s (FEV1) in people with and 
without asthma.7,8
Vitamin A contributes to key biological processes in 
human beings, including growth, vision, epithelial 
diﬀ erentiation, reproduction, and immune responses.9 
The two dietary sources of this vitamin are pre-formed 
vitamin A (retinol) and pro-vitamin A (carotenoids).10 
Dietary intake of retinol comes from animal sources (eg, 
whole milk, liver, and eggs) and fortiﬁ ed foods. Orange–
yellow fruits and vegetables (eg, carrots) are the main 
dietary sources of carotenoids, including α-carotene, 
β-carotene, and β-cryptoxanthins.
Oxidative stress might exacerbate asthma by increasing 
the release of pro-inﬂ ammatory cytokines, airway 
inﬂ ammation, and airway responsiveness.4,5,11 Vitamin A 
might improve prevention or treatment of asthma by 
downregulation of oxidative stress12 or via direct eﬀ ects 
on the immune system.13 For example, vitamin A 
downregulates T-helper (Th)2 (pro-allergic) immune 
responses by increasing proliferation of T-regulatory 
cells14,15 and inhibiting Th17 (pro-inﬂ ammatory) cells.16 
However, vitamin A also enhances Th2 immune 
responses (eg, interleukin 4 expression).17 Carotenoids 
might promote balanced Th1 or Th2 immune responses,18 
and lycopene supplementation reduces allergic airway 
inﬂ ammation,19 decreases concentrations of circulating 
interleukin 4 and interleukin 5,19 and increases 
interferon-γ expression20 in murine models.
In 2009, Allen and colleagues21 undertook a systematic 
review and (when methodologically appropriate) a 
meta-analysis of 21 observational studies of dietary 
intake or serum concentration of vitamin A (or its 
components) and asthma outcomes in children and 
adults (not including studies of prenatal diet or prenatal 
antioxidant levels). Self-reported dietary intake of 
vitamin A or its components (retinol and carotenoids) 
was inversely associated with asthma (diﬀ erence for 
comparison of cases vs controls–182 μg per day, 95% CI 
–288·4 to –75·3) and asthma severity (diﬀ erence for 
comparison of severe vs mild disease –344 μg per day, 
95% CI –575·2 to –112·6). However, dietary intake of 
vitamin A was not signiﬁ cantly associated with wheeze 
or airway responsiveness.21
In 2010, Nurmatov and colleagues22 examined pre-natal 
and post-natal dietary intake or serum concentration of 
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Key messages
• Inadequate evidence exists to recommend nutritional 
supplementation with any speciﬁ c vitamin or methyl 
donor to prevent or treat asthma
• Evidence supports undertaking of randomised controlled 
trials for: vitamin D to prevent or treat asthma; choline as 
adjuvant treatment for asthma; and vitamin E to 
ameliorate the negative eﬀ ects of air pollution on asthma
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vitamin A and its components as part of a systematic 
review and meta-analysis of observational studies of diet 
or nutrients for the primary prevention of asthma and 
allergy in children younger than 17 years.22 For vitamin A 
and its components, evidence from 17 studies (including 
three birth cohorts) was deemed methodologically weak 
but possibly supportive of an eﬀ ect on asthma but not on 
wheeze. For carotenoids, ﬁ ndings from two birth cohort 
studies showed no signiﬁ cant association between 
maternal dietary intake during pregnancy and wheeze or 
asthma in the child by the age of 2 years (when a 
conﬁ dent diagnosis of asthma is not possible).23–25
Since the publication of these two systematic 
reviews,21,22 investigators of a longitudinal study of 
17 528 Norwegian adults (aged 19–55 years) noted that 
daily consumption of cod liver oil (containing vitamin A 
[1000 μg/5 mL] and vitamin D [400 IU/5 mL]) was 
signiﬁ cantly associated with increased odds of incident 
asthma over a follow-up of 11 years (adjusted odds ratio 
[OR] 1·6, 95% CI 1·3–2·0).26 Limitations of this study 
include potential selection bias (about 26% of 
participants had missing data for cod liver oil intake), 
exclusion of children, and possible residual confounding 
by cigarette smoking or vitamin D intake.
No primary randomised controlled trial (RCT) of 
vitamin A for the prevention or treatment of asthma has 
been done. However, Checkley and colleagues27 did a 
secondary analysis in subgroups of Nepalese adults and 
children participating in two RCTs of vitamin A 
supplementation (administered for 16 months) to prevent 
mortality in children younger than 6 years, and vitamin A 
or β-carotene supplementation during pregnancy to 
prevent pregnancy-related mortality. In this analysis, 
neither vitamin A nor β-carotene supplementation (to pre-
school children [n=3879] or pregnant women [n=1551]) 
was signiﬁ cantly associated with asthma or wheeze (at 
adolescence or young adulthood in the ﬁ rst trial, and at 
school age in the second trial). Although the investigators 
had previously reported that vitamin A supplementation 
during pregnancy leads to increased lung function (FEV1 
and forced vital capacity [FVC]) in school-aged Nepalese 
children,28 they recorded no signiﬁ cant results for FEV1 or 
FVC (a marker of airﬂ ow obstruction and asthma 
severity29) in their new analysis. This study was limited by 
potential selection bias due to loss of follow-up (ranging 
from about 18% to about 40%), variability in the dose 
given to pre-school children, and possible confounding by 
additional vitamin A supplementation received as part of a 
nationwide programme.
Higher intake of tomatoes, carrots, and leafy vegetables 
(which are rich in carotenoids such as α-carotene, 
β-carotene, lutein, and zeaxanthin) has been associated 
with lower prevalence of asthma in women.30 Of the pro-
vitamin A carotenoids, β-carotene has been most intensely 
studied because of its protective properties against the 
eﬀ ects of free radicals and oxidative damage. A meta-
analysis of ﬁ ve observational studies showed that high 
dietary intake of β-carotene was not signiﬁ cantly associated 
with asthma or FEV1.31 However, this meta-analysis was 
limited by sample size and residual confounding. Results 
of two RCTs showed that modiﬁ cation of dietary intake of 
carotenoids or lycopene through a diet rich in fruits and 
vegetables32 or (lycopene-rich) tomato extract and tomato 
juice33 improved indicators of asthma control, including 
lung function measures and time to disease exacerbations 
in adults with asthma. Larger RCTs (including both 
children and adults) with longer follow-up are needed to 
further validate these ﬁ ndings.
Vitamin C
Vitamin C (ascorbic acid), a potent water-soluble 
antioxidant found in various fruits and vegetables, has 
been associated with lower risks of cardiovascular 
disease, stroke, and cancer.34 An anti-inﬂ ammatory role 
for vitamin C is further supported by the ﬁ nding that 
vitamin C supplementation reduces C-reactive protein 
(CRP) in individuals with raised CRP concentrations.35 
Vitamin C could have beneﬁ cial eﬀ ects on asthma 
through its immune-modulatory (eg, prostaglandin 
inhibition), antioxidant, or anti-inﬂ ammatory prop-
erties. In experimental models, vitamin C has been 
linked to decreased airway responsiveness, and reduced 
peri vascular and peribronchiolar inﬁ ltration by 
inﬂ ammatory cells.36,37 In support of this hypothesis, 
results of a cross-sectional study of Turkish children 
showed reduced plasma concentrations of vitamin C 
(and other non-enzymatic antioxidants such as vitamin 
E and carotenoids) in patients with asthma.38 Similarly, 
an increase of 1 standard deviation in serum concen-
trations of vitamin C and other non-enzymatic 
antioxidants (eg, β-carotene and selenium) was 
associated with a reduction in asthma prevalence in a 
study of US children.39
In their systematic review and meta-analysis of 
32 observational studies in children and adults, Allen 
and colleagues21 reported that low dietary intake of 
vitamin C (variably deﬁ ned across studies as lowest 
tertile or quintile, or as a low intake level [eg, <56 or 
<60 mg per day]) was signiﬁ cantly associated with slightly 
increased odds of asthma (OR 1·12, 95% CI 1·04–1·20), 
with generally consistent results for wheeze and airway 
responsiveness, but null ﬁ ndings for asthma severity.21 
Conversely, Nurmatov and colleagues22 reported metho-
dologically weak and unsupportive evidence of an eﬀ ect 
of vitamin C on the development of asthma or atopy in 
their review of 14 studies (including three birth cohorts).22 
The discrepant conclusions of these two meta-analyses 
are probably connected to major diﬀ erences in the 
criteria for study inclusion—eg, Allen and colleagues’ 
study did not include birth cohorts. After publication of 
these reviews, investigators of a cross-sectional study of 
1964 Greek children aged 1–3 years reported that dietary 
intake of vitamin C was signiﬁ cantly and inversely 
associated with wheeze, but not with asthma.40
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In 2009, a Cochrane review of nine RCTs (aggregate 
sample size of 330 participants) of vitamin C 
supplementation and asthma outcomes (symptoms, 
lung function measures, total IgE, or use of inhaled 
steroids) concluded that insuﬃ  cient evidence exists to 
recommend a role for vitamin C in the treatment of 
asthma.41 No primary RCT of vitamin C supplementation 
to prevent asthma has been done. However, investigators 
of a secondary analysis of an RCT of vitamin C (1000 mg) 
and vitamin E (400 IU RRR α-tocopherol) supplementation 
to prevent pre-eclampsia in pregnant women recorded 
no signiﬁ cant eﬀ ects on asthma or respiratory symptoms 
in the oﬀ spring of participants at age 2 years42 Longer 
follow-up of children participating in this study could 
further understanding of the association between 
vitamin C and childhood asthma.
Vitamin E
Vitamin E comprises several fat-soluble components 
with distinct antioxidant properties.10 Vitamin E occurs 
naturally in eight chemical forms—α, β, γ, and 
δ-tocopherol, and α, β, γ, and δ-tocotrienol—of which 
α-tocopherol has the greatest bioavailability. Dietary 
sources of vitamin E include nuts, seeds, green 
vegetables, and vegetable oils. Vitamin E might help to 
prevent or treat asthma by downregulating oxidative 
stress, airway inﬂ ammation, and Th2-immune responses 
(eg, reducing production of interleukin 4 by human 
peripheral blood mononuclear cells).13,43 The antioxidant 
and anti-inﬂ ammatory properties of vitamin E are 
supported by ﬁ ndings from an unblinded trial, which 
showed that administration of a vitamin E isoform 
(d-α-tocopherol) for 16 weeks reduced F2 isoprostanes (a 
marker of oxidative stress) in bronchoalveolar lavage 
ﬂ uid and airway responsiveness to methacholine (but not 
to speciﬁ c allergens) in adults with mild atopic asthma.44 
Notably, plasma γ-tocopherol is inversely associated with 
total IgE and allergic sensitisation in adults.45,46
In their review and meta-analysis of 24 observational 
studies of vitamin E in children and adults, Allen and 
colleagues21 reported a signiﬁ cant association between 
low self-reported dietary intake and physician-diagnosed 
asthma (diﬀ erence for comparison of cases and controls 
–1·91 mg per day, 95% CI –2·5 to –1·3 mg per day) but 
not with self-reported asthma, wheeze, or airway 
responsiveness. Lower dietary intake (but not serum 
concentration) of vitamin E was also signiﬁ cantly 
associated with increased asthma severity.21 From a 
review of 15 observational studies (including three birth 
cohorts), Nurmatov and colleagues22 concluded that the 
evidence linking vitamin E intake during pregnancy to 
wheeze or asthma in childhood was methodologically 
weak but suﬃ  ciently supportive of a potential eﬀ ect, 
warranting follow-up in clinical trials.
Pearson and colleagues47 showed no eﬀ ect of vitamin E 
supplementation (500 mg per day) for 6 weeks on airway 
responsiveness in an RCT in 72 British adults with 
asthma. Consistent with this lack of eﬀ ect of vitamin E 
on asthma morbidity, investigators of a second RCT 
reported that an antioxidant supplement (containing 
β-carotene, vitamin C, and vitamin E) had no eﬀ ect on 
plasma F2 isoprostanes, exhaled nitric oxide, or immune 
responses of peripheral blood mononuclear cells in 
54 adults with allergy (deﬁ ned as a doctor-diagnosed 
allergic rhinitis or asthma, and sensitisation to at least 
one allergen).48 By contrast with these negative results, 
four RCTs have reported that vitamin E-containing 
antioxidants reduce ozone-induced bronchoconstriction 
in patients with49,50 and without51,52 asthma, which 
suggests a potential protective eﬀ ect of vitamin E against 
the detrimental eﬀ ects of ozone. Although no primary 
RCT of vitamin E supplementation to prevent asthma 
has been done, a secondary analysis of an RCT of 
vitamin C and vitamin E supplementation to prevent pre-
eclampsia in pregnant women showed no eﬀ ect on 
respiratory function in the oﬀ spring at age 2 years.42
A question that remains outstanding is whether 
vitamin E obtained from foods has diﬀ erent eﬀ ects from 
vitamin E obtained from supplements. A pilot study 
conﬁ rmed the feasibility of a food-based RCT to increase 
vitamin E intake to 15 mg per day in pregnant women;53 
However, whether this method of increasing vitamin E 
intake would yield better results than the use of 
supplements is unknown.
Vitamin D
Vitamin D is a nutrient and hormone that is key to the 
metabolism of calcium and phosphorus. Vitamin D is 
primarily acquired from sun exposure, with diet (eg, oily 
ﬁ sh and dairy products) and supplements as secondary 
sources. Vitamin D status is assessed by measurement of 
the major circulating form of vitamin D—namely, serum 
or plasma 25-hydroxyvitamin D3 (25[OH]D).54 The terms 
vitamin D deﬁ ciency (a serum concentration of 
25[OH]D <20 ng/mL) and vitamin D insuﬃ  ciency 
(20–29 ng/mL) are commonly used, but an expert panel 
in the USA proposed a single threshold (≥20 ng/mL) as 
suﬃ  cient for musculoskeletal health.55 This threshold is 
controversial, however, because no consensus has been 
reached on vitamin D suﬃ  ciency for non-musculoskeletal 
(eg, respiratory) health.56 Irrespective of the threshold 
used, reduced serum or plasma vitamin D concentrations 
are commonly detected in children and adults in the 
USA, particularly in subgroups at high risk for asthma or 
asthma morbidity—eg, African Americans, Puerto 
Ricans, and obese people.57,58
Although the eﬀ ects (if any) of vitamin D on asthma 
and asthma morbidity are not fully understood, they 
might include regulation of gene expression or immune 
responses (eg, upregulation of regulatory T cells59), 
aﬀ ecting lung development or function, preventing 
weight gain,60 attenuating or preventing viral illness (a 
common cause of asthma exacerbations), and enhancing 
steroid responsiveness.58 Of these potential eﬀ ects, the 
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most extensively studied are those on viral illnesses and 
steroid responsiveness. Findings from observational 
studies and RCTs suggest that vitamin D has a more 
consistent and stronger eﬀ ect against viral respiratory 
illnesses in children61–63 than in adults.64 Results from 
observational and experimental studies65–70 also suggest 
that vitamin D insuﬃ  ciency or deﬁ ciency is associated 
with decreased steroid responsiveness. Consistent with 
ﬁ ndings for viral illnesses, the eﬀ ects of vitamin D on 
steroid responsiveness might be stronger in children 
than in adults.71
In 2011, Paul and colleagues58 reviewed the ﬁ ndings of 
ten observational studies72–81 (including seven birth 
cohorts75–81) of dietary intake or serum concentration of 
vitamin D and asthma, concluding that evidence for a 
causal link is insuﬃ  cient. Since then, investigators of six 
observational studies (two cross-sectional82,83 and four 
longitudinal,84–87 including two birth cohorts84,85) in 
children83–86 or adults60,82 have reported an inverse 
association82,83 or no association84–87 between serum or 
cord blood vitamin D concentration and asthma. Of the 
six published birth cohort studies that followed up at 
least 750 children each, one yielded negative results for 
asthma or wheeze at age 6 years,85 whereas ﬁ ve reported 
an inverse association between vitamin D status during 
pregnancy (assessed as maternal dietary intake, or 
maternal serum or cord blood vitamin D concentration) 
and wheeze76–78,80 or asthma79 between the ages of 1·3 and 
5 years. All these birth cohort studies had substantial loss 
of follow-up (ranging from around 24% to around 53%), 
which could have led to selection bias.
Three population-based studies (two cross-sectional57,88 
and one longitudinal70) showed an association between 
reduced serum vitamin D concentrations and severe 
disease exacerbations or core measures (eg, 
hospitalisations) of severe exacerbations in Costa Rican, 
North American, and Puerto Rican children with asthma. 
In the most recent of these studies,57 vitamin D 
insuﬃ  ciency or deﬁ ciency (a serum 25[OH]D 
concentration <30 ng/mL) was associated with increased 
odds of one or more severe asthma exacerbations in the 
previous year in Puerto Rican children, even after 
adjustment for household income, African racial 
ancestry, time spent outdoors, and other covariates. 
Notably, this association was stronger in non-atopic 
children (OR 6·2, 95% CI 2·1–21·2, p<0∙01) than in 
atopic children (2·0, 95% 1·0–4·1, p=0·04), suggesting 
that vitamin D aﬀ ects the risk of severe asthma 
exacerbations through mechanisms other than regulation 
of allergic immune responses—eg, modulation of viral 
illnesses or corticosteroid responses. Consistent with 
ﬁ ndings for severe exacerbations in children with 
(predominantly) mild to moderate asthma, reduced 
vitamin D concentrations are associated with increased 
airway smooth muscle mass, decreased lung function, 
and worse disease control in children with severe, 
therapy-resistant asthma.89
Results of ongoing RCTs of vitamin D supplementation 
during pregnancy to prevent asthma in childhood 
(NCT00920621, NCT00856947) or (as add-on therapy) 
treatment failure in adulthood (NCT01248065) have not 
yet been published.58 In view of the present evidence, a 
clinical trial of vitamin D supplementation to prevent 
severe asthma exacerbations in school-aged children is 
both justiﬁ able and necessary.
Nutrients acting as methyl donors
DNA methylation, a type of epigenetic regulation, is a 
mechanism underlying some gene–environment 
interactions on complex diseases such as asthma.90 
In particular, changes in DNA methylation can aﬀ ect the 
pathogenesis of asthma by increasing or decreasing the 
expression of disease-susceptibility genes.
DNA methylation is catalysed by enzymes that 
transfer methyl groups (methyl-transferases) from the 
methylating agent S-adenosylmethionine to cytosine. 
In human beings, methyl donors for DNA methylation 
are mostly derived from dietary methyl groups. Folate-
dependent and choline-dependent pathways interact at 
the point that homocysteine is converted to methionine 
for derivation of S-adenosylmethionine.91 In the ﬁ rst 
pathway, tetrahydrofolates and vitamin B12 are cofactors 
required by methionine synthase. In the second 
pathway, the methylation of homocysteine to form 
methionine is catalysed by betaine homocysteine 
methyltransferase.91–93 Both transmethylation metabolic 
pathways closely interconnect with methyltetra-
hydrofolate, B12, choline, and methionine. Methyl 
donors aﬀ ect DNA methylation and, potentially, 
immune responses (ﬁ gure).
Folate, a type of water-soluble vitamin B and a cofactor 
(as tetrahydrofolates) in the transfer of one-carbon 
moieties, has a key role in aminoacid metabolism, purine 
and pyrimidine synthesis, and formation of 
S-adenosylmethionine. Dark leafy vegetables, fortiﬁ ed 
cereals and bread are major dietary sources of folate. 
Folate deﬁ ciency is associated with neural tube defects in 
embryos, macrocytic anaemia, cardiovascular diseases, 
and cancer.94 Because of its known preventive eﬀ ects 
against neural tube defects, folate supplements are 
routinely prescribed to women who are pregnant or 
planning to conceive.95 Vitamin B12 (cobalamin) is 
necessary for proper formation of red blood cells, 
neurological function, and DNA synthesis, and is found 
in meat (especially liver), poultry, ﬁ sh and shellﬁ sh, eggs, 
milk, and milk products. Vitamin B12 deﬁ ciency is 
associated with neural tube defects, cardiovascular 
diseases, cognitive decline, macrocytic anaemia, and 
osteoporosis.96 Choline is a lipotropic agent involved in 
several biological functions (eg, neurotransmitter 
production, signalling lipids, and components of 
structural membranes), and as a methyl group donor.97 
Dietary sources of choline include meat, liver, eggs, 
poultry, ﬁ sh and shellﬁ sh, peanuts, and cauliﬂ ower. 
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Choline deﬁ ciency is associated with neurological 
disorders, cardiovascular diseases, and inﬂ ammation.98
Nutrients acting as methyl donors could contribute to 
asthma risk by aﬀ ecting DNA methylation and, 
ultimately, gene expression. In a mouse model, a 
maternal diet rich in methyl donors (including folic acid, 
vitamin B12, and choline) during pregnancy resulted in 
increased severity of allergic airway disease99 in 
the F1 (oﬀ spring) generation and (to a lesser extent) the 
F2 generation. This dietary eﬀ ect is probably mediated by 
dysregulation of lymphocyte maturation and enhancing 
Th2 immune responses.99 This eﬀ ect, in turn, is probably 
caused by DNA methylation of genes that are crucial to 
Th1 and Th2 immune balance (eg, Runx3, which is 
implicated in negative regulation of allergic airway 
disease in mice).99 Although these ﬁ ndings have 
generated substantial interest, their relevance to human 
beings is unclear because of the high doses of methyl 
donors used in the dietary intervention and scarcity of 
data supporting the eﬀ ects of individual methyl donors 
(eg, folic acid).
To our knowledge, no animal models of the eﬀ ects of 
exclusive folate intake or exclusive vitamin B12 intake on 
experimental asthma (allergic airway disease) have been 
published. Intranasal or oral administration of choline, 
however, has been shown to reduce the number of 
eosinophils and reactive oxidant species in 
bronchoalveolar lavage ﬂ uid in a murine model of 
allergic airway disease.100 Together with ﬁ ndings in 
adults101,102 and adolescents102 with101 and without102 asthma, 
this suggests that choline might attenuate (and not 
enhance) allergic inﬂ ammation in general and airway 
inﬂ ammation in particular.
Results from experimental studies and the recom-
mendation of folic acid supplementation in women who 
are pregnant or planning to conceive have triggered 
observational studies in children and adults. Because of 
their longitudinal design, birth cohort studies can best 
examine whether folate status or folic acid supple-
mentation during pregnancy is associated with the 
development of asthma or atopy. However, not all birth 
cohort studies on this topic have gathered data for either 
maternal dietary intake or folate level in early 
pregnancy.23,103–112 Of these 11 studies, seven showed no 
signiﬁ cant association between maternal folic acid intake 
(through diet and supplements) and asthma;23,103,105,107,108,110,111 
three of these negative studies had a short duration of 
follow-up,23,103,111 (limiting their assessment of asthma, 
which is diﬃ  cult before the age of 6 years) and the rest 
lost a large proportion of children to follow-up. Although 
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the results of four birth cohort studies104,106,111,112 showed a 
positive association between folate status during 
pregnancy and asthma or atopy, they were limited by 
short duration of follow-up, non-comprehensive 
phenotypic assessment, or inconsistent results for 
asthma and atopy. The authors of the largest of these 
positive studies (n=32 077) noted that folic acid 
supplementation during pregnancy was associated with 
slightly increased risk of wheeze (adjusted relative risk 
1·06, 95% CI 1·03–1·10) and lower respiratory tract 
infections in infancy.104 Only three birth cohort studies 
have assessed biomarkers of folate.110–112 In two of these 
studies,110,111 maternal folate status during pregnancy 
(assessed by measurement of plasma111 or intracellular110 
folic acid concentration) was not associated with 
childhood asthma. In the third study,112 maternal plasma 
folate concentration in the second trimester of pregnancy 
was signiﬁ cantly and linearly associated with increased 
odds of asthma at age 3 years. However, none of these 
studies has separately measured folate species (vitamers). 
Whether folate status aﬀ ects disease severity or control 
in people who already have asthma is unclear.113
Two cross-sectional studies in adults yielded negative 
ﬁ ndings for dietary intake or circulating concentration of 
vitamin B12 and asthma or atopy.114,115 Additionally, 
investigators of two birth cohort studies reported no 
signiﬁ cant association between maternal dietary intake 
or circulating B12 concentration during pregnancy and 
wheeze in young children, yielding conﬂ icting ﬁ ndings 
for eczema or atopic dermatitis.103,111 We are not aware of 
published birth cohort studies of choline status during 
pregnancy and asthma or atopy.
No RCTs have been done on methyl donor supple-
mentation during pregnancy to prevent asthma. This 
absence of research is understandable for folate because 
of weak and conﬂ icting evidence from observational 
studies, and ethical concerns about withholding or 
reducing folic acid supplementation during conception 
or pregnancy because of its documented beneﬁ cial 
eﬀ ects. Although no RCTs of folate or vitamin B12 
supplementation to treat asthma have been published, 
Mehta and colleagues101 did a 6-month RCT to examine 
the eﬀ ects of choline supplementation (1500 mg, twice 
per day) on indicators of disease severity or control in 
76 Indian adults with asthma. In this trial, choline 
supplementation led to reductions in symptoms, 
medication use, concentrations of cytokine (interleukin 4, 
interleukin 5, and tumour necross factor-α), and airway 
responsiveness.
Discussion
Several nutrients or vitamins with antioxidant or anti-
inﬂ ammatory eﬀ ects, acting additively or synergistically, 
could have beneﬁ cial eﬀ ects on asthma. For example, 
whereas increased intake of fruits and vegetables decreases 
the risk of asthma,30,32 a so-called westernised diet—eg, rich 
in meats, sodium, and reﬁ ned carbohydrates—increased 
the risk of frequent wheezing.116 Thus, well designed 
observational studies and RCTs of particular diets or 
dietary patterns would be justiﬁ able and of great interest, 
particularly as a diet rich in fruits and vegetables and low 
in saturated fats or carbohydrates has known beneﬁ ts to 
overall health. However, such a diet is not always easy to 
adhere to because of practical reasons, including cultural 
beliefs and ﬁ nancial limitations. Speciﬁ c circumstances 
(such as area of residence, work habits, or fear of being 
outdoors because of safety concerns [eg, exposure to 
violence]) could limit sun exposure, which is a main 
determinant of circulating vitamin D concentrations. 
Thus, supplementation of beneﬁ cial vitamins or nutrients 
could be a relatively inexpensive and practical alternative 
for some populations with asthma or at risk of developing 
asthma.
All observational studies (cross-sectional and 
longitudinal) of vitamins or nutrients acting as methyl 
donors are susceptible to bias due to diﬀ erential entry or 
retention of participants according to both the exposure 
and outcome of interest (selection bias), confounding by 
environmental or lifestyle factors (eg, socioeconomic 
status, physical activity, intake of other nutrients), and 
false-positive results due to multiple testing. Additionally, 
cross-sectional studies are subject to reverse causation 
(ie, if the disease leads to increased or decreased 
concentrations of a particular vitamin or nutrient) and 
recall bias. Furthermore, most observational studies do 
not have adequate statistical power to test for interactions 
between the vitamin or nutrient of interest and other 
dietary components because of the sample sizes usually 
used in these studies. Despite these limitations, 
observational studies are often helpful in deciding 
whether to undertake an RCT and to prioritise the need 
for a particular RCT. Although RCTs remain the gold 
standard to determine whether a vitamin or nutrient 
aﬀ ects asthma, small or poorly conducted trials might be 
subject to false negatives, residual confounding (eg, if 
the two groups being compared are not balanced with 
regard to potential confounders), or bias due to 
diﬀ erential adherence to treatment or insuﬃ  cient dosing 
or duration of the intervention of interest.
The ﬁ gure shows some of the potential mechanisms of 
action of methyl donors and vitamins (A, C, E, and D) on 
immune responses. Tables 1 and 2 summarise evidence 
linking vitamins or nutrients acting as methyl donors to 
asthma or asthma morbidity. Of the four vitamins of 
interest, data from observational studies support ongoing 
or future RCTs of vitamin D supplementation for the 
prevention or treatment of asthma (eg, to prevent severe 
disease exacerbations). Findings for vitamins A, C, and E 
best support a large RCT of vitamin E supplementation 
to ameliorate the detrimental eﬀ ects of air pollution on 
disease morbidity in patients with asthma. For 
vitamins A, C, and E, additional follow-up of children in 
ongoing birth cohort studies could help to prioritise the 
need for RCTs of primary prevention.
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Recommendations for fortiﬁ cation of foods or 
supplementation of folic acid to women of childbearing 
age were established after the peak in the asthma 
epidemic in industrialised countries. This fact, combined 
with evidence from observational studies, suggests that 
any eﬀ ect of folate status on development of asthma is 
likely to be small, and should thus be assessed in the 
context of ongoing large birth cohort studies, preferably 
with biomarkers in addition to dietary information. 
At present, adequate observational studies of folate status 
and asthma morbidity do not exist. Whereas little 
evidence exists for a role of vitamin B12 in the pathogenesis 
of asthma or asthma morbidity, data from a single RCT 
support large RCTs of choline supplementation to treat 
asthma in patients with established disease. In view of 
existing data, birth cohort studies of choline status and 
asthma are also justiﬁ ed.
In summary, there is insuﬃ  cient evidence to 
recommend the use of any vitamin supplement or 
nutrient acting as methyl donor for the prevention or 
Potential mechanisms of action Observational studies RCTs
Vitamin A Downregulation of oxidative stress 
and Th2 (allergic) immune responses
Findings from >20 studies (including three birth cohorts) provide weak 
evidence for an inverse association between dietary intake and asthma 
(but not wheeze). Prenatal or postnatal vitamin A supplementation was 
not signiﬁ cantly associated with asthma, wheeze, or FEV1/FVC in children. 
Intake of vitamin A and D (as cod liver oil) was associated with incident 
asthma in a study of adults
No primary RCT of vitamin A to prevent or treat asthma in 
children or adults has been done
Vitamin C Downregulation of oxidative stress 
and Th2 (allergic) immune responses
Findings from more than 30 studies of postnatal dietary intake suggest an 
inverse association between vitamin C intake and asthma in children and 
adults, with generally consistent results for wheeze and airway 
responsiveness but not asthma severity. When studies of prenatal dietary 
intake are reviewed along with those of postnatal intake, weak and 
inconsistent evidence exists of an association between vitamin C intake 
and asthma or atopy in children
No primary RCT of vitamin C supplementation during 
pregnancy to prevent asthma has been done. Although nine 
RCTs have shown no signiﬁ cant evidence for an eﬀ ect of 
vitamin C supplementation on indicators of asthma severity or 
control, none has had adequate statistical power to detect 
weak to moderate eﬀ ects of vitamin C on asthma morbidity
Vitamin D Enhanced steroid responsiveness, 
antiviral properties, upregulation of 
T-regulatory cells, prevention of 
gains in adiposity, eﬀ ects on lung 
development or function
Results from six of seven birth cohort studies with sample size 
>750 mother–child pairs support an inverse association between maternal 
vitamin D status during pregnancy and asthma or wheeze in childhood. 
Longer follow-up is necessary to properly assess an association with 
asthma in all six positive studies. Findings from three studies (one 
longitudinal) suggest that vitamin D insuﬃ  ciency or deﬁ ciency is 
associated with increased risk of severe asthma exacerbations
RCTs of vitamin D supplementation during pregnancy to 
prevent asthma have not been done. Similarly, results of RCTs 
of vitamin D supplementation to reduce asthma morbidity in 
children or adults have not been published
Vitamin E Downregulation of oxidative stress, 
airway inﬂ ammation, and Th2 
(allergic) immune responses
Findings from >20 studies of postnatal dietary intake suggest an inverse 
association between vitamin E intake and physician-diagnosed asthma in 
children and adults, with inconsistent results for wheeze, self-reported 
asthma, and airway responsiveness. When studies of prenatal dietary 
intake are reviewed along with those of postnatal intake, weak evidence 
exists of an inverse association between vitamin E intake and asthma or 
atopy in children
No primary RCT of vitamin E supplementation during 
pregnancy to prevent asthma has been done. Although two 
RCTs showed no signiﬁ cant eﬀ ects of vitamin E 
supplementation on airway responsiveness or inﬂ ammatory 
and immune markers in adults with asthma, other ﬁ ndings 
support a protective eﬀ ect of vitamin E supplementation 
against ozone-induced bronchoconstriction
RCTs=randomised controlled trials. FEV1=forced expiratory volume in 1 second. FVC=forced vital capacity. Th2=type 2 helper T cell.
Table 1: Collective ﬁ ndings of studies and trials of potential eﬀ ects of vitamins on asthma
Potential mechanisms of action Observational studies RCTs
Folate Diﬀ erential DNA methylation of 
genes aﬀ ecting Th1/Th2 immune 
responses, ultimately enhancing 
Th2 (allergic) immune responses 
and airway inﬂ ammation
Findings from 20 observational studies (including 
11 birth cohorts) do not support moderate or strong 
eﬀ ects of folate on asthma or atopy. Two studies with 
major methodological weaknesses provide 
insuﬃ  cient evidence to assess a potential association 
between folate and asthma severity or control
No primary RCT of folic acid supplementation to 
prevent or treat asthma in children or adults has 
been done
Vitamin B12 If any, similar to those listed for 
folate
Four studies (including two birth cohorts) showed no 
signiﬁ cant association with wheeze or asthma, with 
conﬂ icting results for eczema or atopic dermatitis 
from the two birth cohort studies
No primary RCT of vitamin B12 supplementation to 
prevent or treat asthma has been done
Choline Downregulation of oxidative 
stress, eosinophilia, and allergic 
airway inﬂ ammation
None, to our knowledge No primary RCT of choline supplementation 
during pregnancy to prevent asthma has been 
done. Findings from an RCT in adults with asthma 
showed that choline supplementation reduces 
symptoms, medication use, airway responsiveness, 
and circulating concentrations of Th2 cytokines
RCTs=randomised controlled trials. Th=T-helper cells. 
Table 2: Collective ﬁ ndings of studies and trials of potential eﬀ ects of nutrients acting as methyl donors on asthma
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treatment of asthma. Ongoing RCTs should help conﬁ rm 
or refute promising ﬁ ndings for vitamin D and choline 
in the prevention or treatment of asthma.
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